Related Experiment Video
Updated: Aug 11, 2026

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein
Published on: March 9, 2015
On the discovery and development of CFTR chloride channel activators
1Institut de Physiologie et Biologie Cellulaires CNRS UMR 6187, Université de Poitiers, 40 Avenue du Recteur Pineau 86022 Poitiers, France. frederic.becq@univ-poitiers.fr
Abstract:
Chloride channels play important roles in vital cellular signalling processes contributing to homeostasis in both excitable and non-excitable cells. Since 1987, more than ten ion channel genes have been identified as causing human hereditary diseases among them the genes for the voltage-dependent chloride channel ClC-1 (myotonia) and the cystic fibrosis transmembrane conductance regulator (CFTR) protein (cystic fibrosis). The CFTR gene was cloned in 1989 and its protein product identified as an ATP-gated and phosphorylation-regulated chloride channel during the following two years. Since then, searching for potent and specific small molecules able to modulate normal and mutated CFTR has become a crucial endpoint in the field for both our understanding of the physiological role that CFTR plays in epithelial cells and more importantly for the development of therapeutic agents to cure cystic fibrosis (CF). It is predicted that a pharmacological approach would help not only to restore the defective transport activity of mutant CFTR but also to correct the regulatory function of CFTR. This review describes the evolution of CFTR pharmacology and how during the last five years, high throughput screening assays have been developed to identify novel molecules, some of them probably constituting a reservoir of future therapeutic agents for CF.
Insights
Researchers are developing new drugs to treat cystic fibrosis (CF) by targeting the cystic fibrosis transmembrane conductance regulator (CFTR) protein. High-throughput screening is identifying novel molecules to restore CFTR function and potentially cure CF.
Area of Science:
- Cellular Biology
- Molecular Biology
- Medical Genetics
Background:
- Chloride channels are crucial for cellular homeostasis.
- Mutations in ion channel genes, including CFTR, cause hereditary diseases like cystic fibrosis.
- The CFTR protein functions as an ATP-gated and phosphorylation-regulated chloride channel.
Purpose of the Study:
- To review the evolution of CFTR pharmacology.
- To highlight the development of high-throughput screening assays for identifying CFTR modulators.
- To discuss the potential of small molecules as therapeutic agents for cystic fibrosis.
Main Methods:
- Literature review focusing on CFTR pharmacology.
- Analysis of high-throughput screening assay development over the last five years.
- Identification of novel small molecules modulating CFTR function.
Main Results:
- Significant advancements in understanding CFTR's physiological role.
- Development of robust screening assays for identifying CFTR modulators.
- Discovery of potential therapeutic agents for cystic fibrosis.
Conclusions:
- Pharmacological modulation of CFTR offers a promising therapeutic strategy for cystic fibrosis.
- Novel small molecules identified through screening may restore defective CFTR transport and regulatory functions.
- Continued research in CFTR pharmacology is essential for developing effective treatments for CF.
More Related Videos
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
06:59A Fluorescence-Based Assay of Membrane Potential for High-Throughput Functional Study of Two Endogenous Ion Channels in Two Epithelial Cell Lines
Published on: June 22, 2022
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pharmacogenomics: Identification of New Drug Targets
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Drug Discovery: Overview
Transcellular Transport of Solutes
Facilitated Transport